Probiotics-related Clostridium butyricum bacteraemia after COVID-19, confirmed by whole-genome sequencing

Yuya Kawamoto; Masahiro Suzuki; Mitsunaga Iwata; Yuki Uehara

doi:10.1136/bcr-2024-261578

Probiotics-related Clostridium butyricum bacteraemia after COVID-19, confirmed by whole-genome sequencing

Yuya Kawamoto
, Masahiro Suzuki
, Mitsunaga Iwata
, Yuki Uehara

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

1 被引用数 (Scopus)

抄録

A man in his 70s was admitted to an intensive care unit with severe COVID-19 and treated with dexamethasone and tocilizumab. After recovery from COVID-19, he developed Clostridium butyricum bacteraemia and non-occlusive mesenteric ischaemia, with fatal outcome. He had been prescribed C. butyricum MIYAIRI 588 fine granules as probiotics for a month. The genome sequences of the C. butyricum isolate from the blood culture and C. butyricum MIYAIRI 588 fine granules were identical by single nucleotide polymorphism analysis. This is the first case of definitive probiotics-related C. butyricum bacteraemia after treatment of severe COVID-19.

本文言語	英語
論文番号	e261578
ジャーナル	BMJ Case Reports
巻	17
号	8
DOI	https://doi.org/10.1136/bcr-2024-261578
出版ステータス	出版済み - 03-08-2024
外部発表	はい

All Science Journal Classification (ASJC) codes

医学一般

文献へのアクセス

10.1136/bcr-2024-261578

他のファイルとリンク

引用スタイル

@article{7747e8008364450c96a06b8084c08f75,

title = "Probiotics-related Clostridium butyricum bacteraemia after COVID-19, confirmed by whole-genome sequencing",

abstract = "A man in his 70s was admitted to an intensive care unit with severe COVID-19 and treated with dexamethasone and tocilizumab. After recovery from COVID-19, he developed Clostridium butyricum bacteraemia and non-occlusive mesenteric ischaemia, with fatal outcome. He had been prescribed C. butyricum MIYAIRI 588 fine granules as probiotics for a month. The genome sequences of the C. butyricum isolate from the blood culture and C. butyricum MIYAIRI 588 fine granules were identical by single nucleotide polymorphism analysis. This is the first case of definitive probiotics-related C. butyricum bacteraemia after treatment of severe COVID-19.",

keywords = "Adult intensive care, COVID-19, Infection (gastroenterology), Mechanical ventilation",

author = "Yuya Kawamoto and Masahiro Suzuki and Mitsunaga Iwata and Yuki Uehara",

note = "Publisher Copyright: {\textcopyright} BMJ Publishing Group Limited 2024. No commercial re-use. See rights and permissions. Published by BMJ.",

year = "2024",

month = aug,

day = "3",

doi = "10.1136/bcr-2024-261578",

language = "English",

volume = "17",

journal = "BMJ Case Reports",

issn = "1757-790X",

publisher = "BMJ Publishing Group",

number = "8",

}

TY - JOUR

T1 - Probiotics-related Clostridium butyricum bacteraemia after COVID-19, confirmed by whole-genome sequencing

AU - Kawamoto, Yuya

AU - Suzuki, Masahiro

AU - Iwata, Mitsunaga

AU - Uehara, Yuki

N1 - Publisher Copyright: © BMJ Publishing Group Limited 2024. No commercial re-use. See rights and permissions. Published by BMJ.

PY - 2024/8/3

Y1 - 2024/8/3

N2 - A man in his 70s was admitted to an intensive care unit with severe COVID-19 and treated with dexamethasone and tocilizumab. After recovery from COVID-19, he developed Clostridium butyricum bacteraemia and non-occlusive mesenteric ischaemia, with fatal outcome. He had been prescribed C. butyricum MIYAIRI 588 fine granules as probiotics for a month. The genome sequences of the C. butyricum isolate from the blood culture and C. butyricum MIYAIRI 588 fine granules were identical by single nucleotide polymorphism analysis. This is the first case of definitive probiotics-related C. butyricum bacteraemia after treatment of severe COVID-19.

AB - A man in his 70s was admitted to an intensive care unit with severe COVID-19 and treated with dexamethasone and tocilizumab. After recovery from COVID-19, he developed Clostridium butyricum bacteraemia and non-occlusive mesenteric ischaemia, with fatal outcome. He had been prescribed C. butyricum MIYAIRI 588 fine granules as probiotics for a month. The genome sequences of the C. butyricum isolate from the blood culture and C. butyricum MIYAIRI 588 fine granules were identical by single nucleotide polymorphism analysis. This is the first case of definitive probiotics-related C. butyricum bacteraemia after treatment of severe COVID-19.

KW - Adult intensive care

KW - COVID-19

KW - Infection (gastroenterology)

KW - Mechanical ventilation

UR - https://www.scopus.com/pages/publications/85200530434

UR - https://www.scopus.com/pages/publications/85200530434#tab=citedBy

U2 - 10.1136/bcr-2024-261578

DO - 10.1136/bcr-2024-261578

M3 - Article

C2 - 39097326

AN - SCOPUS:85200530434

SN - 1757-790X

VL - 17

JO - BMJ Case Reports

JF - BMJ Case Reports

IS - 8

M1 - e261578

ER -

Probiotics-related Clostridium butyricum bacteraemia after COVID-19, confirmed by whole-genome sequencing

抄録

All Science Journal Classification (ASJC) codes

文献へのアクセス

他のファイルとリンク

フィンガープリント

引用スタイル